Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver
- Most recent report
- 6-K, filed Sep 25, 2026
- Filings on record
- 39 filings
- On EDGAR
- CIK 1751912
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 15
- 6-K Report a foreign issuer made public elsewhere Sep 25, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 24, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 13, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 2, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 1, 2026
- 6-K Report a foreign issuer made public elsewhere May 26, 2026
- 6-K Report a foreign issuer made public elsewhere May 22, 2026
- 6-K Report a foreign issuer made public elsewhere May 18, 2026
Prospectuses and Registrations 2
Other 8 of 22
Everything here comes from Nervgen Pharma Corp.'s own filings on SEC EDGAR. The filing list is rechecked every hour.